In the last trading session, 4.59 million shares of the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) were traded, and its beta was 1.09. Most recently the company’s share price was $0.51, and it changed around $0.01 or 3.33% from the last close, which brings the market valuation of the company to $185.01M. LXRX currently trades at a discount to its 52-week high of $2.45, offering almost -380.39% off that amount. The share price’s 52-week low was $0.28, which indicates that the current value has risen by an impressive 45.1% since then. We note from Lexicon Pharmaceuticals Inc’s average daily trading volume that its 10-day average is 19.86 million shares, with the 3-month average coming to 15.28 million.
Lexicon Pharmaceuticals Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.17. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 3 recommended LXRX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) trade information
Instantly LXRX has showed a green trend with a performance of 3.33% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.5885 on recent trading dayincreased the stock’s daily price by 13.34%. The company’s shares are currently down -30.70% year-to-date, but still up 22.18% over the last five days. On the other hand, Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) is 43.36% up in the 30-day period. We can see from the shorts that 43.88 million shares have been sold at a short interest cover period of 1.41 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 91.5% from its current value. Analyst projections state that LXRX is forecast to be at a low of $6 and a high of $6.
Lexicon Pharmaceuticals Inc earnings are expected to increase by 41.27% in 2025, but the outlook is positive 22.79% per year for the next five years.
LXRX Dividends
Lexicon Pharmaceuticals Inc’s next quarterly earnings report is expected to be released on 2025-Mar-05.
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.17% of Lexicon Pharmaceuticals Inc shares, and 84.10% of them are in the hands of institutional investors. The stock currently has a share float of 85.09%. Lexicon Pharmaceuticals Inc stock is held by 170.0 institutions, with ARTAL GROUP S.A. being the largest institutional investor. By 2024-06-30, it held 56.3318% of the shares, which is about 175.1 million shares worth $294.17 million.
FMR LLC, with 12.4462% or 38.69 million shares worth $64.99 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund and Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 16.86 shares worth $8.63 million, making up 4.66% of all outstanding shares. On the other hand, Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund held roughly 5.4 shares worth around $2.76 million, which represents about 1.49% of the total shares outstanding.
